Maxicure

#Manufacturing #Pharmaceuticals/OTC
ProHub Comment

This is a classic operations and capital allocation case that tests a candidate's ability to structure options (refurbish, rebuild on-site, rebuild elsewhere, or outsource), perform quantitative analysis (break-even at 110M units), and think strategically about implementation (tax incentives for relocation). The case progressively increases complexity from strategic options to financial modeling to stakeholder management.

Estimated Time 26 minutes
Difficulty Medium
Source Darden
10 / 100
Your client, Maxicure, manufactures and sells an over-the-counter cough and cold medicine. Their sole plant in Kentucky is aging, and its increasing maintenance costs are leading to low margins on their products. How would you advise Maxicure proceed to solve this problem?

Clarifying Information

  1. There are 2-3 larger players in this over-the-counter business who have distribution across the country. Maxicure is one of them.
  2. Maxicure sells all of its products in the US
  3. Objective is to reduce production costs while maintaining product quality (cost, quality and brand image all matter to customers).
Mock Interview
Interviewer

Your client, Maxicure, manufactures and sells an over-the-counter cough and cold medicine. Their sole plant in Kentucky is aging, and its increasing maintenance costs are leading to low margins on their products. How would you advise Maxicure proceed to solve this problem?

You

Thanks. Before analyzing, I'd like to clarify a few key questions...

Interviewer

Good question. Let me provide some background information...

You

Based on this, I suggest analyzing from these dimensions...

AI Score
Structure Analysis Communication Business Sense Quantitative
Practicing...
Score coming soon
Practice this case with AI Mock Interview

Maxicure faces margin compression from aging Kentucky plant maintenance costs. The case requires candidates to compare four strategic options, then analyze the profitability threshold between building a new Indiana facility versus outsourcing to a competitor (break-even: 110M bottles), and finally propose negotiation strategy with state officials for tax incentives.

Key Insights:

  1. Break-even analysis reveals in-house production becomes more profitable than outsourcing at 110M units, incorporating both the $50M capital investment and tiered outsource pricing ($2.25 for first 20M, $2.50 thereafter)
  2. Strategic decision requires balancing quantitative factors (cost, investment, margins) with qualitative factors (quality control, brand image, distribution proximity, technology improvements)
  3. Relocation to Indiana near distribution center requires framing to state officials using economic development arguments (tax revenue, job creation, economic stimulus, competitive advantage for attracting other manufacturers)